Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

NCT05397496 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin Lymphoma (B-NHL)
B-cell Acute Lymphoblastic Leukemia (B-ALL)

Interventions

BIOLOGICAL: PIT565

Sponsor

Novartis Pharmaceuticals